Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Small cell lung cancer Small Cell Lung Cancer SCLC Othman Saleh Grand Valley State University Small cell lung cancer 1a. Presenting signs and symptoms of patient (history and physical) A 57 year- old white male was diagnosed with a small cell carcinoma of the lung. Patient presented earlier in the fall of 2014 and at that time the doctor found abnormality with his imaging. He mentioned that he discontinued tobacco use approximately 2- ½ years ago after approximately an 80-pack-year history and reports social use of ethanol. In addition, he reports that his parent had skin cancer. 2a. Epidemiology Lung cancer is a form of cancer that originates in the lungs. Like any other cancers, it results from an abnormality in the cell. An article titled, Lung Cancer: Epidemiology, Etiology, and Prevention, stated that “lung cancer is the leading cause of cancer death in the United States and around the world. Almost as many Americans die of lung cancer every year than die of prostate, breast, and colon cancer combined.” As mentioned lung cancer claims more lives each year than other cancers combined, that’s how deadly and serious lung cancer is. There are three main types of lung cancer; non-small cell, small cell, and carcinoid. 1. Non-Small Cell Lung Cancer According to American Cancer Society, “About 85% to 90% of lung cancers are nonsmall cell lung cancer (NSCLC).” There are 3 leading subtypes of NSCLC. The cells in these subtypes vary in mass, form, and chemical make-up. American Cancer Society declared about 25% to 30% of all lung cancers are squamous cell carcinomas, 40% of lung cancers are adenocarcinomas, and 10% to 15% of lung cancers are large cell carcinoma. Small cell lung cancer 2. Small Cell Lung Cancer About 10% to 15% of all lung cancers are small cell lung cancer (American Cancer Society 2015). 3. Lung Carcinoid Tumor Carcinoid tumors of the lung account for fewer than 5% of lung tumors (American Cancer Society 2015). Overall, including both small cell and non-small cell, The American Cancer Society’s estimates for lung cancer in the United States for 2015 are: ◾ “About 221,200 new cases of lung cancer (115,610 in men and 105,590 among women) ◾ And estimated 158,040 deaths from lung cancer (86,380 in men and 71,660 among women), accounting for about 27% of all cancer deaths.” 1c. Etiology (study the causes of a disease) risk factors The book, Lung Cancer discussed many causes and risk factors related to lung cancer. It discussed some cancer- causing substances such as tobacco smoke, asbestos, radon, family history and so forth. According to Lung Cancer, lung cancer is caused by a mutation in your DNA. The authors discussed how the body is built to fight, protect, and repair itself from any damage; however with constant exposure to carcinogens, the body becomes weak to fight off damages done to the body. In addition, Healthline explains in more details how carcinogens can affect the body and cause diseases like cancer to develop. Healthline states, “Lung cancer is caused by a mutation in your DNA. When cells reproduce, they divide and replicate, forming Small cell lung cancer identical cells, so that your body is constantly renewing itself. Inhaling harmful, cancer-causing substances (carcinogens) like cigarette smoke, asbestos, and radon, damages the cells that line your lungs. At first your body may be able to repair itself. With repeated exposure your cells become increasingly damaged. Over time, the cells begin to act abnormally and grow uncontrollably. This is how cancer can develop.” Our immune systems constantly fight off diseases but too much of everything is always bad. Being exposed to carcinogens is commonly negative but we always get exposed to carcinogens somehow by environmental factors such as pollution, radiation, and asbestos. But in some situations like smoking tobacco is where people expose themselves to additional carcinogens, and that’s where it becomes too much. Tobacco smoke Smoking is the main cause for lung cancer. American Cancer society mentioned that lung cancer is more familiar now compared to other types of cancer than in the early 20th century because cigarette became freely available and more people began smoking. According to American Cancer Society, “At least 80% of all lung cancer deaths are thought to result from smoking, and this number is probably even higher for small cell lung cancer. It is very rare for someone who has never smoked to have small cell lung cancer.” Basically they’re mentioning how significant smoking relates to lung cancer. It’s mentioned that it’s almost unheard of for someone to develop small cell lung cancer if he or she never smoked. This basically tells me that smoking is almost 100% obvious to be the cause of small cell lung cancer. Secondhand smoke: Small cell lung cancer If a person doesn’t smoke, being exposed to secondhand, breathing in the smoke of others smoke at home, work, or in restaurants and bars can put him or her at a great risk of developing lung cancer. Secondhand smoke is believed to takeaway more than 7,000 lives from lung cancer each year (Healthline 2015) Environmental factors Radon Centers for Disease Control and Prevention, CDC, states, “According to the U.S. Environmental Protection Agency (EPA), radon causes about 20,000 cases of lung cancer each year, making it the second leading cause of lung cancer. Nearly one out of every 15 homes in the U.S. is thought to have high radon levels. Radon comes from rocks and dirt and can get surrounded in houses and buildings. Most houses in United States have a basement and most of radon gas can be present there. It’s dangerous, because as mentioned it’s the second leading cause of lung cancer and it cannot be identified with the five senses. For safety purpose and lung cancer prevention, it’s better to test the place of shelter in case there is a high level of radon. Other Substances CDC listed substances found at some workplaces that place the staffs at higher risk of developing lung cancer. These substances include asbestos, arsenic, diesel exhaust, and some forms of silica and chromium. It was mentioned that combing both, smoking and being exposed to such substances, puts a person in a greater risk of developing lung cancer. American Cancer Society stated, “Workplace exposure to asbestos fibers is an important risk factor for lung cancer. Studies have found that people who work with asbestos (in some mines, mills, textile plants, places where insulation is used, shipyards, etc.) are several times more likely to die of lung cancer. In workers exposed to asbestos who also smoke, the lung cancer risk is much Small cell lung cancer greater than even adding the risks from these exposures separately.” So again, somehow we will be exposed to some substances due to the environment we live in. however, creating a greater risk goes back to the person and being aware to avoid additional carcinogens. Family History The authors of the book, Lung Cancer, mentioned that if a person has a family member who has or has had lung cancer puts him or her at a higher risk of developing the disease. Also, if a person has had cancer, he or she is in higher risk of developing it again. Age American Cancer Society stated, “Lung cancer mainly occurs in older people. About 2 out of 3 people diagnosed with lung cancer are 65 or older; fewer than 2% of all cases are found in people younger than 45. The average age at the time of diagnosis is about 70.” In my understanding, age contribute to the development of lung cancer if it can be understood because aging process is complex. A person can be old but in perfect mental and physical shape. However, if a person is old and became weaker; that’s when aging becomes significant as a risk of developing cancer because a person body might not function fully as strong as once was. 1d. Compare patient to typical The patient is 57 years of age which placed him at a higher risk of developing lung cancer. As mentioned earlier under the age section, fewer than 2% of all cases are found in people younger than 45 but more common for people over the age of 45 to develop lung cancer. However, the known age is 65 where people get diagnosed of lung cancer. Moreover, the patient used to smoke approximately an 80-pack-year history, which placed him at a greater risk since Small cell lung cancer smoking is number one risk factor of developing lung cancer. In addition to smoking, he probably exposed to environmental factors such as radon, air pollution, asbestos, arsenic, and diesel exhaust, which created a greater risk. The patient mentioned that his parent had skin cancer, which can connect to genetics and placed him at a higher risk of developing cancer. 2. Complete patient work-up information (chronological in table form) Based on what was found in patient chart. Date Procedure Lab Tests October 10, 2014 Imaging October 21, 2014 Biopsy Right hilar and peritracheal mass Specimen 1: imprint cytology Specimen 2: Fine needle aspiration cytology October 22, 2014 MRI Brian November 25, 2014 Multiple scientigraphic images Evaluate for metastases Lab Results Diagnosis Abnormal imaging 1-2 right lower lobe endobronchial imprint cytology and FNA station 7 No areas of photopenia are identified. Bilateral renal excretion is seen with a small amount of radiotracer activity with the bladed Positive small cell carcinoma Lung carcinoma, light headedness, vertigo, weakness Nothing to suggest metastatic disease. Degenerative changes of the appendicular and axial skeleton. Small cell lung cancer December 30, 2014 Imaging Comparison January 21, 2015 consultation Treatment options February 3, 2015 simulation treatment No significant change Radiation therapy Linear accelerator 3a. Anatomy and physiology discussion The lungs are a pair of spongy air-filled organs located on either side of the thorax. The main purpose of the lungs is to exchange gases between the air we breathe and blood. Carbon dioxide is removed from the bloodstream and oxygen enters the bloodstream. The right lung consists of three lobes; the superior, middle, and inferior lobes. The horizontal fissure separates the superior and the middle lobes, while the right oblique fissure divides the middle and inferior lobes. The left lung consists of two lobes; superior and inferior lobes separated by the left oblique fissure. The trachea inhale air into the lungs through the bronchi. The bronchi then divide into smaller branches known as bronchioles, and finally reach a bunch of small air sacs called alveoli; where the oxygen from the air is absorbed into lung. Carbon dioxide is a waste product leaves from the blood to the alveoli, where it can be exhaled. The lungs are protected by a thin tissue called the pleura, it serves as a lubricant allowing the lungs to expand and contract with each breath (WebMD 2015). Refer to the anatomy & lymphatic section for graphical detail. Muscles and Bones The diaphragm is the strong wall of muscle that separates the chest cavity from the abdominal cavity. The ribs are bones supporting and protecting the chest cavity. They move to help the lungs expand and contract (American lung Association 2015). Small cell lung cancer 3b. Regional lymphatic drainage The lymphatic system is significant in lung cancer because it is one of the major routes of regional spread. Left and right lower lobe as well as the right middle lobe lymphatics drain to the posterior mediastinum and subcarinal lymph nodes. Right upper lobe lymphatics drain toward the superior mediastinum, whereas the left upper lob lymphatics typically course lateral to the aorta and subclavian artery in the anterior mediastinum along the left main bronchus to the superior mediastinum. Ultimately, all of these lymphatic channels drain into the right lymphatic or left thoracic ducts, which empty into the subclavian veins. Basically, most of the lymphatic drainage ultimately reaches the right superior mediastinum and right supraclavicular regions (LWWOncology 2015). Refer to the anatomy & lymphatic section for graphical detail. 3c. Anatomy & lymphatic graphics The Lungs (Human Anatomy): Picture, Function, Definition, Conditions. (n.d.). Retrieved April 8, 2015, from http://www.webmd.com/lung/picture-of-the-lungs Small cell lung cancer Lungs. (n.d.). Retrieved April 8, 2015, from http://medicalterms.info/anatomy/Lungs/ GUWS Medical. (2015, April 1). Retrieved April 8, 2015, from http://www.guwsmedical.info/heart-failure/nerves-of-the-thoracic-wall.html Small cell lung cancer 4a. Pathology Small cell lung cancer, also known as oat cell carcinoma, differs from non-small cell lung cancers due to their clinical and biologic characteristics. It’s known as an aggressive type of lung cancer. It is a neuroendocrine carcinoma that shows destructive behavior, fast growth, and early spread to regional sites. Small cell lung carcinoma (SCLC) arises in peribronchial sites and penetrates the bronchial submucosa (Medscape 2015). There two types of small cell cancer lung cancer; small cell carcinoma (oat cell cancer) and combined small cell carcinoma. Symptoms of SCLC may include blood sputum, chest pain, coughing, loss of appetite, shortness of breath, weight loss, fever, and swallowing difficulty. However, most of SCLC gets discovered usually after it has already spread to other parts of the body. Bone scan, chest x-ray, complete blood count, CT scan, MRI, and liver function tests are examinations that detect or diagnose lung cancer. Moreover, biopsy can be done to identify if the disease is present (Midline Plus 2015). 4b. staging Staging system is a typical way to figure out how large a cancer is and if it has spread. There are two staging systems that are used to describe the stage of SCLC. Limited and extensive stage Limited stage- cancer is only in the chest and can be treated with radiation therapy. Lymph nodes superior to the clavicle can be affected in limited stage. About 1 out of 3 people with SCLC has limited stage when cancer is first found. Small cell lung cancer Extensive stage- cancer has spread outside the chest. About 2 out of 3 people have extensive disease when their cancer is diagnosed. SCLC is staged this way for treatment purposes (American Cancer Society 2015). The TNM staging system TNM is recognized system used to describe the growth and spread of lung cancer. TNM system describes 3 keys of information; T describes the size of the tumor, N describes the spread to regional lymph nodes, and M describes whether the cancer has metastasized to other organs. Numbers or letters are added after T, N, and M to offer more detailed information. T categories for lung cancer TX: The main tumor can’t be assessed. T0: There is no evidence of a primary tumor. Tis: Cancer is found only in the top layers of cells lining the air passages. It has not grown into deeper lung tissues. This is also known as carcinoma in situ. T1: The tumor is not greater than 3 centimeters, and has not extended to the pleura and does not affect the main branches of the bronchi. T2: The tumor has 1 or more of the following features: It is greater than 3 cm across but not more than 7 cm. It involves a main bronchus, but is not closer than 2 cm to the carina It has grown into the pleura. The tumor partially clogs the airways, but this has not caused the entire lung to collapse or develop pneumonia. T3: The tumor has 1 or more of the following features: It is larger than 7 cm across. It has grown into the chest wall, diaphragm, the mediastinal pleura, or parietal pericardium. It invades a main bronchus and is closer than 2 cm (to the carina, but it does not involve the carina itself. Small cell lung cancer It has grown into the airways enough to cause an entire lung to collapse or to cause pneumonia in the entire lung. Two or more separate tumor nodules are present in the same lobe of a lung T4: The cancer has 1 or more of the following features: A tumor of any size has grown into the mediastinum, the heart, the aorta, trachea, the esophagus, the backbone, or the carina. Two or more separate tumor nodules are present in different lobes of the same lung. N categories for lung cancer NX: Nearby lymph nodes cannot be assessed. N0: There is no spread to nearby lymph nodes. N1: The cancer has spread to lymph nodes within the lung and/or around the area. N2: The cancer has spread to lymph nodes around the carina or mediastinum. N3: The cancer has spread to lymph nodes near the collarbone on either side, and/or spread to hilar or mediastinal lymph nodes on the side opposite the primary tumor. M categories for lung cancer M0: No spread to distant organs or areas. M1a: Any of the following: The cancer has spread to the other lung Cancer cells are found in the fluid around the lung Cancer cells are found in the fluid around the heart M1b: The cancer has spread to distant lymph nodes or to other organs such as the liver, bones, or brain Stage grouping for lung cancer Stage 1 T1,M0,N0 Stage 2 T1,N1,M0 Stage 3 T1-3, N2,M0 Stage 4 Any T, any N,M1 - (American Cancer Society 2015) T2,N0,M0 T3,N0,M0 T3,N1,M0 Any T,N3,M0 T4,N2,M0 Small cell lung cancer 4c. Grading Grade refers to the appearance of the individual cancer cells under the microscope. Cancer grading helps to find patient’s prognosis and survival outlook. Tumor grading is determined by taking cancerous tissues through biopsy and microscopically tests for cell characteristics and aggressiveness. The test tissues can be graded as high or low depending on their status. High grading tells us that the cancer is aggressive, poor differentiated, grow faster, and spread faster. Low grading means that cancer is well differentiated, less aggressive, and likely to spread. The book titled as Cancer Staging Handbook from the American Joint Committee on Cancer (AJCC) discussed specifically tumor grading for SCLC. Grade Gx : Grade cannot be assessed G1 : Well differentiated G2 : Moderately differentiated G3 : Poor differentiated G4 : Undifferentiated 4d. Patients pathology, stage and grade Pathology samples were obtained through biopsy and were sent to the lab. The lab results indicated that the patient is diagnosed of a small cell carcinoma of the lung. Primary tumor was present in the right lower lobe with a mass measuring 7.6 x4.5 cm. In addition, it has spread to the right upper lobe nodular lesion, measuring 1.4 x 1.3 cm. There was no evidence of Small cell lung cancer metastasis. However, there was a large mass present with in the mediastinum and right suprahilar region. According to the staging and the patient’s chart, the patient’s disease is limited. According to the TNM staging, his tumor can be classified a T3 (It is larger than 7cm), N3 (The cancer has spread to lymph nodes to hilar or mediastinal lymph nodes), and M0 (no spread to other organs). By grouping T3, N3, M0; the patient’s cancer falls under stage 3. 5a. Radiation Therapy (RT) treatment plan and Rx for patient Following simulation and using image fusion treatment planning, a six-field intensity modulated radiation therapy was developed. The patient was treated to the right lung mediastinum using 6 MV photons. Patient chart discussed a total of 6,000 cGy to be delivered in 30 fractions of 200 cGy per fraction. 5b. RT treatment information and patient set-up The patient setup up was supine, head first, with the aid of an alpha-cradle and a sponge underneath his knees in order to reproduce the same setup for every treatment and provide an accurate and precise treatment. 5c. RT treatment type and how it was delivered Beam AP RPO Chest RPO RPO Chest RAO Chest RAO Chest Chest Gantry 0.0 200 230 260 300 330 0.0 0.0 0.0 0.0 0.0 0.0 angles Collimator angles Small cell lung cancer Couch 0.0 0.0 0.0 0 0 0 Wedges None None None None None None Block MLC MLC MLC MLC MLC MLC Bolus None None None None None None Planned 89.2 cm 87.1 cm 82.1 cm 79.7 cm 85.5 cm 87.2 cm 52.3 MU 48.5 MU 66.1 MU 64.7 MU 50.2 MU 58.2 MU 6 MV 6 MV 6 MV 6 MV 6 MV 6 MV Photons Photons Photons Photons Photons Photons angles SSD Monitor Units Energy 5d. RT complication and side effect and how they were treated According to the chart, the patient was having some fatigue and having some early dysphagia, which are common side effects of radiation therapy. It was recommended for him to drink a lot of fluid. 6a. Adjuvant therapies (traditional), complications and side effect and how they are treated Treatment options are based on the stage of the cancer and overall health of the patient. As mentioned earlier, small cell lung cancer are typically staged as either limited or extensive. Unfortunately, SCLC spread by the time it is diagnosed, so surgery might not be a good option for treatment. Chemotherapy and radiation therapy the other main options for lung cancer. Moreover, if the patient is a smoker, it’s better for him or her to quit before treatment. American Small cell lung cancer Cancer society states, “Studies have shown that patients who stop smoking after a diagnosis of lung cancer tend to have better outcomes than those who don’t.” Chemo therapy is the use of cancer killing drugs taking by mouth or injected into the body. The side effects of chemotherapy are hair loss, fatigue, constipation, anemia, loss of appetite, and bleeding problems. Radiation therapy is a method of delivering how dose of radiation to a specific volume while sparing other critical organs, this can be done by internal or external. Side effects of radiation therapy may include dysphagia, difficulty breathing, fatigue, skin irritation, and weight loss. Treatment options for each stage are as follow: Limited Stage SCLC Most of patients with limited stage SCLC are treated with both chemo and radiation. Surgery is not a preferred option when the tumor is too large or it has spread to regional lymph nodes and other parts in the chest. Chemo drugs such as etoposide plus either cisplatin or carboplatin are used. Combining chemo and radiation is called concurrent chemoradiation. This gives them a better outcome and prognosis (American cancer society 2015). Extensive stage SCLC Patients with limited extensive SCLC and are in good overall health to undergo chemo, it can often treat symptoms helps patient live longer. The most commonly used combination is etoposide plus either cisplatin or carboplatin. Most patients will benefit from it when the tumor shrinks. Unfortunately, the cancer will reoccur at some point in their life; this happens to almost all patients with extensive stage SCLC (American cancer society 2015). 6b. what other therapies (6a) and complications did patient have? Small cell lung cancer According to the patient chart, he went through radiation therapy and chemotherapy. 7. Critical structures and dose tolerances Radiation beam pass through the following structures when treating lung cancer. The table information below was taking from a book titled, Principle and Practice of Radiation Therapy by Washington and Leaver. Structures Side Effects TD 5/5 (cGy) Spinal cord Neurologic complications, 5000 fibrosis, and occlusion of capillaries. Normal lung Pneumonitis, fibrosis 2000 Heart Pericarditis 4300 Esophagus Acute esophagitis 5000 Bone marrow Suppression 2500 Skin Necrosis, ulcerate on 5500 Liver Liver diseases 3500 Bone Necrosis 6500 Small cell lung cancer 8. Routes of spread A book by the tittle, Decision Making in Radiation Oncology, declared the three most common routes of spread in lung cancer; local extension, regional spread to the lymphatics, and distant metastasis. The authors explained more detailed as follow: Local extension “Direct involvement of pleural surfaces, chest wall, ribs, and mediastinal structures causing hemoptysis. Involvement of vertebral body, brachial plexus, stellate ganglion, subclavian caculature and superior vena cava. Regional lymph node metastasis Lymph node drainage includes the hilar and interlobar nodes, followed by mediastinal lymph nodes. Mediastinal nodal routes of spread differ between upper and lower lobe tumors. Distant metastasis Most common sites of distant metastasis are contralateral lung, brain, bone, adrenals, and liver” (p.265). Small cell lung cancer 9a. Prognosis and survival Small cell lung cancer prognosis and survival can vary significantly between patients. Patient’s age, stage, and overall health status play major role for treatment options and prognosis. The table information below was taking from a book titled, Principle and Practice of Radiation Therapy by Washington and Leaver. 9b. Patients prognosis and survival After grouping the TNM staging system; T3, N3, and M0, patient fall under the stage 3. Unfortunately, small cell lung cancer is aggressive and deadly. The patient has 8% chance of a 5 year survival. Small cell lung cancer Work Cited What is small cell lung cancer? (14, October 12). Retrieved April 9, 2015, from http://www.cancer.org/cancer/lungcancer-smallcell/detailedguide/small-cell-lung-cancerwhat-is-small-cell-lung-cancer Ganti, A. (2013). Lung cancer. New York, NY: Oxford University Press. Lung Cancer Causes. (n.d.). Retrieved April 9, 2015, from http://www.healthline.com/health/lung-cancer-causes#TrendingNow4 Cruz, C., Tanoue, L., & Matthay, R. (n.d.). Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine, 605-644. Retrieved April 9, 2015. What are the risk factors for non-small cell lung cancer? (2014, August 15). Retrieved April 9, 2015, from http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/nonsmall-cell-lung-cancer-risk-factors What Are the Risk Factors for Lung Cancer? (2014, May 6). Retrieved April 9, 2015, from http://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm The Lungs (Human Anatomy): Picture, Function, Definition, Conditions. (n.d.). Retrieved April 8, 2015, from http://www.webmd.com/lung/picture-of-the-lungs How Lungs Work - American Lung Association. (n.d.). Retrieved April 8, 2015, from http://www.lung.org/your-lungs/how-lungs-work/ Small cell lung cancer What are the key statistics about lung cancer? (2014, September 12). Retrieved April 8, 2015, from http://www.cancer.org/cancer/lungcancer-smallcell/detailedguide/small-cell-lungcancer-key-statistics LWW Oncology | Texts. (n.d.). Retrieved April 9, 2015, from http://www.lwwoncology.com/Textbook/Toc.aspx?id=11000 Lu, J. (2011). Lung Cancer. In Decision making in radiation oncology (p. 265). Berlin: Springer. Small Cell Lung Cancer . (n.d.). Retrieved April 9, 2015, from http://emedicine.medscape.com/article/280104-overview#a0101 How is small cell lung cancer staged? (2014, September 12). Retrieved April 9, 2015, from http://www.cancer.org/cancer/lungcancer-smallcell/detailedguide/small-cell-lung-cancerstaging Treatment choices by stage for small cell lung cancer. (2014, September 12). Retrieved April 9, 2015, from http://www.cancer.org/cancer/lungcancer-smallcell/detailedguide/small-celllung-cancer-treating-by-stage Washington, Charles M., and Dennis T. Leaver. "Introducation to Radiation Therapy." Principles and Practice of Radiation Therapy. 3rd ed. St. Louis, MO: Mosby, 2010. 666681. Print.